Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Low-dose depot medication in schizophrenia

P L Burnett1, C A Galletly, R J Moyle

  • 1Hillcrest Hospital, South Australia.

Schizophrenia Bulletin
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spigelian hernia: a multi-site review of operative outcomes of surgical repair in the adult population.

Hernia : the journal of hernias and abdominal wall surgery·2024
Same author

Performance measures of 16- to 86-year-old males and females on the auditory verbal learning test.

The Clinical neuropsychologist·2017
Same author

Expression of a New Cellular Protein by Monocytoid B-Lymphocytes Differentiated from the Acute Lymphoblastic Leukemia Cell Line (REH).

Leukemia & lymphoma·2016
Same author

04-01 Abnormal recruitment of brain networks during trauma-neutral verbal working memory processing in PTSD.

Acta neuropsychiatrica·2016
Same author

04-02 Topography of event-related potentials to visuoverbal working memory updating and target detection in PTSD.

Acta neuropsychiatrica·2016
Same author

11-03 Identifying cognitive and affective markers within an integrative neuroscience model of ADHD.

Acta neuropsychiatrica·2016

Low-dose depot antipsychotics for schizophrenia may improve psychosocial function and reduce side effects. However, positive symptoms might increase, necessitating temporary dose adjustments to manage relapses.

Area of Science:

  • Psychiatry
  • Pharmacology

Background:

  • Depot antipsychotic medication is crucial for schizophrenia maintenance therapy.
  • Optimal dosing strategies for these medications remain unclear.

Purpose of the Study:

  • To review studies comparing low-dose versus standard-dose depot antipsychotics.
  • To evaluate the impact on various outcome measures in schizophrenia treatment.

Main Methods:

  • Systematic review of published studies over the last decade.
  • Analysis of outcome measures including psychosocial function, side effects, and positive symptoms.

Main Results:

  • Low-dose treatment generally enhances psychosocial function and decreases side effects compared to standard doses.
  • An increase in positive symptoms was observed with low-dose regimens.

Related Experiment Videos

  • Temporary dose increases effectively managed symptoms and terminated relapse episodes.

    • Conclusions:

    • Low-dose depot antipsychotics offer benefits in psychosocial function and tolerability.
    • Careful monitoring for positive symptoms and potential for dose adjustment are essential for effective schizophrenia management.